Service Quote Request
Please fill out the form below with your detailed inquiry.
Both DREADDs (chemogenetics) and optogenetics allow precise control of defined cell populations, especially neurons, but they differ fundamentally in how stimulation is delivered, the temporal resolution achieved, and experimental complexity.
| Feature | DREADDs (Chemogenetics) | Optogenetics |
|---|---|---|
| Control modality | Designer drug (systemic or local) | Light (laser/LED) |
| Receptor/Protein | Engineered GPCR (e.g., hM3Dq, hM4Di) | Light-gated ion channels/pumps (e.g., ChR2, ArchT) |
| Temporal resolution | Slow (minutes to hours) | Very fast (milliseconds) |
| Spatial precision | Cell-type specific, whole-body drug exposure | Highly precise, light-targeted region |
| Invasiveness | No implant required after injection | Requires optical fiber or LED implant (in vivo) |
| Duration of effect | Long-lasting (hours) | Only during illumination |
| Typical use | Modulating behavior, physiology | Precise circuit mapping, spike control |
| Technical complexity | Moderate | High |
How it works:
Cells express engineered GPCRs activated only by synthetic ligands (e.g., CNO, DCZ, C21). Ligand delivery activates intracellular signaling pathways.
Key characteristics
Common functional variants
Best suited for
How it works:
Cells express light-sensitive ion channels or pumps. Light delivery directly controls membrane potential.
Key characteristics
Common opsins
Best suited for
✅ Long-lasting modulation
✅ Minimal surgical hardware
✅ Whole-brain or systemic effects
✅ Behavioral or physiological studies over hours
✅ Simpler in vivo workflows
✅ Precise control of spike timing
✅ Rapid on/off switching
✅ Sub-second temporal resolution
✅ Region-specific stimulation
✅ Mechanistic circuit dissection
Many studies combine both approaches:
👉 DREADDs = Pharmacological remote control (slow, long-lasting, low invasiveness)
👉 Optogenetics = Light-based neural switch (fast, precise, hardware-dependent)